COVID-19 third wave depends on people’s behaviour: AIIMS Director Randeep Guleria
The Director of Delhi AIIMS, Randeep Guleria on Friday (August 13, 2021) said the second wave of the COVID-19 pandemic is not yet over and the third wave depends on the COVID-appropriate behaviour by the people.
Aug 14, 2021, 07:27 AM IST
Not much data to suggest Delta Plus variant more infectious, says AIIMS chief Randeep Guleria
AIIMS chief Dr Randeep Guleria said, “There isn't much data on Delta plus variant to suggest it's more infectious, causing more deaths, or has developed significant immune escape mechanism."
Jul 01, 2021, 12:38 PM IST
Delta plus variant may affect efficacy of COVID-19 vaccines to some extent: AIIMS Director Dr Randeep Guleria
"Currently, the delta plus is a variant of interest. There is not much data to show that this is becoming dominant or this more infectious or causing more mortalities," AIIMS director Randeep Guleria said on Wednesday.
Jun 17, 2021, 07:03 AM IST
Don't get CT-scans if you have mild COVID-19 symptoms, increases risk of cancer, says AIIMS Director Dr Randeep Guleria
Dr Randeep Guleria further said that several blood tests for biomarkers are also not needed in mild illness
May 03, 2021, 20:12 PM IST
Remdesivir drug should only be administered in hospital setting: AIIMS chief Randeep Guleria
AIIMS Director Randeep Guleria discussing the COVID-19 situation said, “The decision to administer Remdesivir must be taken by a medical professional and administered only in a hospital setting.”
Apr 30, 2021, 20:51 PM IST
Coronavirus puts strain on mental health: AIIMS Director Randeep Guleria
The remarks hold importance on the day the world is observing the `Suicide Prevention Day`.
Sep 10, 2020, 22:40 PM IST
Israel shares AI-based technology, high-end equipment with AIIMS to help combat COVID-19
AIIMS said in a release that the Ambassador of Israel to India Dr Ron Malka formally handed over the high-end equipment and technology solutions to Director of AIIMS Dr Randeep Guleria at an event held today.
Aug 12, 2020, 01:59 AM IST
COVID-19: No benefit of plasma therapy in reducing mortality risk, says AIIMS Director Dr Randeep Guleria
The therapy involves taking antibodies from the blood of a person who has recovered from COVID-19 and transfusing those into an active coronavirus infected patient to help kickstart the immune system to fight back the infection.
Aug 06, 2020, 18:38 PM IST
Lockdown may continue in India's coronavirus COVID-19 hotspots: AIIMS Director Dr Randeep Guleria
Dr Guleria said that coronavirus cases have increased in the hotspot and the need of the hour is to confine it to these places only and efforts should be taken contain the deadly virus from growing in other parts of the country.
Apr 06, 2020, 16:48 PM IST
